Edinger Kylie M, Rao Venkat K
Division of Plastic Surgery. University of Wisconsin, Madison, Wis.
Division of Plastic Surgery, University of Wisconsin, Madison, Wis.
Plast Reconstr Surg Glob Open. 2022 Apr 25;10(4):e4282. doi: 10.1097/GOX.0000000000004282. eCollection 2022 Apr.
Postsurgical pyoderma gangrenosum is a rare condition characterized by ulcerative lesion development at surgical sites. It is frequently misdiagnosed as infection and mismanaged with surgical debridement, which only worsens the condition. Achieving the correct diagnosis is crucial to delivering the appropriate medical therapy. This article presents four clinical cases of postsurgical pyoderma gangrenosum in breast surgery patients, and proposes a work-up schematic to aid in its diagnosis based on literature review and author experience.
Four patients who developed postsurgical pyoderma gangrenosum following breast surgery were identified by chart review at our institution.
The cases include two breast reduction patients, an abdominally based breast reconstruction patient, and a breast augmentation patient. The time to diagnosis and treatment varied greatly between the patients, with diagnosis achieved as early as 13 days postoperatively to as late as one year postoperatively. Two of the four patients were initially mismanaged with surgical debridement, and all patients were treated with at least one course of antibiotics for a misdiagnosis of surgical site infection before they were correctly diagnosed.
Postsurgical pyoderma gangrenosum is a rare, ulcerative condition that is difficult to diagnose and often mismanaged with surgical debridement. Diagnosis requires a high clinical suspicion and should be considered in patients with ulcerative lesions resistant to antibiotic therapy, in patients who have bilateral lesions with NAC sparring, and in those with systemic inflammatory conditions. Diagnosis is usually delayed, so it is imperative that surgeons keep this diagnosis in mind when treating breast patients with postsurgical wounds.
术后坏疽性脓皮病是一种罕见疾病,其特征为手术部位出现溃疡性病变。它常被误诊为感染,并因手术清创处理不当,这只会使病情恶化。做出正确诊断对于提供恰当的药物治疗至关重要。本文介绍了4例乳腺手术患者术后坏疽性脓皮病的临床病例,并根据文献综述和作者经验提出了一个有助于诊断的检查示意图。
通过对我院机构病历审查确定了4例乳腺手术后发生术后坏疽性脓皮病的患者。
这些病例包括2例缩乳手术患者、1例腹部带蒂乳房再造患者和1例隆胸患者。患者之间的诊断和治疗时间差异很大,诊断最早在术后13天,最晚在术后1年。4例患者中有2例最初因手术清创处理不当,所有患者在被正确诊断之前都因手术部位感染的误诊而接受了至少一个疗程的抗生素治疗。
术后坏疽性脓皮病是一种罕见的溃疡性疾病,难以诊断,且常因手术清创处理不当。诊断需要高度的临床怀疑,对于对抗生素治疗有抵抗的溃疡性病变患者、双侧病变且保留乳头乳晕复合体的患者以及患有全身性炎症疾病的患者应考虑此病。诊断通常会延迟,因此外科医生在治疗有术后伤口的乳腺患者时必须牢记这一诊断。